Dr. Brzezniak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1860 Town Center Dr
Ste 460
Reston, VA 20190Phone+1 703-437-6535Fax+1 703-437-6549
Education & Training
National Capital ConsortiumFellowship, Hematology and Medical Oncology, 2010 - 2012
Dwight David Eisenhower Army Medical CenterResidency, Internal Medicine, 2007 - 2010
Lake Erie College of Osteopathic Medicine - Seton HillClass of 2007
Certifications & Licensure
VA State License 2018 - 2026
NY State License 2008 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 9 citationsRRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case Report.Christina Brzezniak, Bruno Schmitz, Paul G. Peterson, Aiste Degesys, Bryan Oronsky
Case Reports in Oncology. 2016-01-15 - 32 citationsRRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancerDaniel Morgensztern, Michal G. Rose, Saiama N. Waqar, John C. Morris, Patrick C. Ma
British Journal of Cancer. 2019-07-30 - 201 citationsSunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trialAnish Thomas, Arun Rajan, Arlene Berman, Yusuke Tomita, Christina Brzezniak
The Lancet. Oncology. 2015-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
